Blood Cancer United (former Leukemia & Lymphoma Society): Translational Research Program (TRP) – LOI

TRP is designed to accelerate the progression of promising scientific discoveries toward clinical application in blood cancers. The TRP supports projects with a clear path to clinical impact. Early-stage or discovery-focused research may be better suited for our Discovery Grant Program (DGP), and applicants with such projects are encouraged to apply through that mechanism.

For the 2027 grant cycle, TRP applications must demonstrate translational readiness. The following criteria apply:

• Small molecule therapies: Applications must include in vivo proof of concept (POC) in appropriate animal models. In select cases, strong in vitro POC using patient-derived samples may be considered, depending on the mechanism of action.
• Cellular and immunotherapies: In vivo POC is strongly encouraged. However, in vitro POC may be acceptable where it is most appropriate for the therapeutic approach.

Funding:  $750,000 over three years.

https://bloodcancerunited.org/research/grants/translational-research-program-trp

https://llsorg.widen.net/s/zgns9bkdj6/en-trp-guidelines-and-instructions-final